Opdivo subkutan 600 mg/5 ml

Opdivo subkutan 600 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 70192. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 January 2026 and the authorisation is limited until 27 January 2031. ATC code L01FF01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 70192
  • ATC L01FF01
  • Biotechnological medicines
Authorisation data
Authorisation number70192
NameOpdivo subkutan 600 mg/5 ml
Full nameOpdivo subkutan 600 mg/5 ml, Injektionslösung
Authorisation holderBristol-Myers Squibb SA
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FF01
First authorisation28 January 2026
Authorisation validity27 January 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Opdivo subkutan 600 mg/5 ml, InjektionslösungA28 January 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FF0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Opdivo subkutan 600 mg/5 ml authorised in Switzerland?

Yes. Opdivo subkutan 600 mg/5 ml is authorised by Swissmedic under authorisation number 70192, data as of 01 September 2026. The authorisation is limited until 27 January 2031.

Which dispensing category does Opdivo subkutan 600 mg/5 ml have?

Opdivo subkutan 600 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Opdivo subkutan 600 mg/5 ml?

The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com